Literature DB >> 28853913

Comparison of the Effects of Osteochondral Autograft Transplantation With Platelet-Rich Plasma or Platelet-Rich Fibrin on Osteochondral Defects in a Rabbit Model.

Masahiro Maruyama1, Hiroshi Satake1, Tomoto Suzuki1, Ryusuke Honma1, Yasushi Naganuma1, Yuya Takakubo1, Michiaki Takagi1.   

Abstract

BACKGROUND: Although osteochondral autograft transplantation (OAT) provides satisfactory outcomes for osteochondral defects, for large defects OAT is often inadequate because of graft availability. Osteochondral allograft transplantation is an alternative treatment for large defects, but this approach is limited by graft storage constraints and carries disease transmission risks. Platelet-rich fibrin (PRF) is a second-generation platelet concentrate, and its positive effect on articular cartilage has been reported. However, the effect of PRF with OAT of osteochondral defects is unknown.
PURPOSE: To compare the effects of OAT with platelet-rich plasma (PRP) and PRF on osteochondral defects in a rabbit model. STUDY
DESIGN: Controlled laboratory study.
METHODS: Forty-two juvenile rabbits were divided into control, PRP, and PRF groups. In the control and PRP groups, a cylindrical osteochondral defect (5 mm in diameter and 2 mm in depth) was created on the patellar groove, and an osteochondral graft (3.5 mm in diameter and 5 mm in length) harvested from the contralateral side was inserted into the distal portion of the defect. After wound closure, either normal saline or PRP was injected in the knee. In the PRF group, a PRF clot was placed in the defect before grafting. The surgical site was macroscopically and histologically assessed after 3 and 12 weeks.
RESULTS: At 3 weeks, the PRF group (n = 8) was macroscopically healed compared with the other 2 groups (control, n = 7; PRP, n = 6) ( P < .005). Histologically, osteochondral graft cartilage of the PRF group had normal cellularity and higher amounts of safranin O staining relative to the other 2 groups ( P < .005). At 12 weeks, all 3 groups (n = 8 per group) were macroscopically healed with normal or nearly normal cartilage, and osteochondral graft cartilage was histologically hyaline cartilage. In contrast, the PRF group healed with hyaline-like cartilage at nongrafted defects, whereas the other 2 groups healed with fibrocartilage ( P < .001).
CONCLUSION: OAT with PRF maintained hyaline cartilage, and the nongrafted defect healed with hyaline-like cartilage. CLINICAL RELEVANCE: PRF has the potential to improve clinical outcomes of OAT used to treat osteochondral lesions.

Entities:  

Keywords:  cartilage; growth factors/healing enhancement; osteochondral autograft transplantation; platelet-rich fibrin; platelet-rich plasma; rabbit model

Mesh:

Year:  2017        PMID: 28853913     DOI: 10.1177/0363546517721188

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  4 in total

1.  The use of platelet-rich fibrin with platelet-rich plasma support meniscal repair surgery.

Authors:  Masahiko Kemmochi; Shigeru Sasaki; Masako Takahashi; Tomitaka Nishimura; Chisa Aizawa; Jun Kikuchi
Journal:  J Orthop       Date:  2018-05-15

2.  Magnetic nanocarriers as a therapeutic drug delivery strategy for promoting pain-related motor functions in a rat model of cartilage transplantation.

Authors:  Xingyu Zhang; Jianjun Yang; Baochang Cheng; Shenli Zhao; Yao Li; Hui Kang; Shiyi Chen
Journal:  J Mater Sci Mater Med       Date:  2021-03-31       Impact factor: 3.896

Review 3.  Biologic Augmentation for the Operative Treatment of Osteochondral Defects of the Knee: A Systematic Review.

Authors:  Deepak V Chona; Stephanie T Kha; Paul D Minetos; Christopher M LaPrade; Constance R Chu; Geoffrey D Abrams; Marc R Safran; Seth L Sherman
Journal:  Orthop J Sports Med       Date:  2021-11-04

4.  Effect of Platelet-Rich Plasma on Autologous Chondrocyte Implantation for Chondral Defects: Results Using an In Vivo Rabbit Model.

Authors:  Yuki Kato; Shinobu Yanada; Hitoshi Morikawa; Takuya Okada; Masatoki Watanabe; Shunsuke Takeuchi
Journal:  Orthop J Sports Med       Date:  2022-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.